2022 — a turning point for US biosimilars?
Cardinal Health says the majority of healthcare providers are keen to use biosimilars despite current market challenges.
February 10, 2022
by CPhIonline
Mental health distress impacting cancer patients, says new Cardinal Health survey of oncologists
More than 80% of oncologists frequently see mental health distress in their patients with cancer, and more than 90% say it has a significant impact on their health outcomes.
December 10, 2021
by prnewswire
Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics
Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, and Cardinal Health (NYSE: CAH)...
December 3, 2021
by prnasia
Cardinal Health partners with Abbott and Quidel to offer rapid OTC COVID-19 tests
Cardinal Health (NYSE: CAH) today announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19 tests through partnerships with Abbott and Quidel Corporation ("Quidel").
August 11, 2021
by prnewswire
Cardinal Health completes sale of Cordis business to Hellman & Friedman
Cardinal Health and Hellman & Friedman announced the completion of the previously announced sale of Cardinal Health's Cordis business to H&F.
August 3, 2021
by prnasia
New York, drug distributors reach $1.18 billion opioid settlement as national deal looms
The three largest US drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nation-wide opioid epidemic, the state’s attorney general said 20th.
July 22, 2021
by expresspharma